Catalent Inc (NYSE:CTLT)
$ 63.48 0 (0%) Market Cap: 11.52 Bil Enterprise Value: 16.13 Bil PE Ratio: 0 PB Ratio: 3.25 GF Score: 80/100

Catalent Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 07:40PM GMT
Release Date Price: $92.35 (-2.24%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Welcome to Bank of America's 2022 Healthcare Conference live from Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostic tools analyst, also CROs and CMOs. Our next company is Catalent. And with us on Catalent is Tom Castellano, CFO; and Paul Surdez, Head of IR. Gentlemen, thank you for being here. Thanks for making the trip out to Vegas. We've grown up together. We participated in your IPO in 2014. What a difference a 9 year makes -- 8 years. I can't even count anymore. Company was 3% biotech when we did the IPO. It's 50-plus percent now.

Margins were hardly moving. Margins are now really expanding. I mean it's been a really interesting story. I think I'll let you kick it off, Tom, like a recap what's going on, and then I'm going to pepper you with a bunch of questions.

Thomas P. Castellano
Catalent, Inc. - Senior VP & CFO

Yes. No, thanks, Derik. Appreciate the opportunity, and thanks, everyone, for joining. The other thing I'd highlight around the IPO is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot